MAXWELLIA

Maxwellia is a trailblazing, female-founded consumer healthcare company on a mission to widen access to medicines. By transforming prescription-only drugs into consumer friendly over-the-counter (OTC) brands through a process called "switching," Maxwellia empowers people to take control of their health. In 2021, the company made history with the launch of Lovima®, one of the first daily contraceptive pills available without a prescription, hailed as a landmark breakthrough in women’s health. Founded by Anna Maxwell, a pharmacist and self care visionary and based at the Alderley Park Life Sciences Hub in Greater Manchester, Maxwellia has developed and commercialised multiple women’s health brands, including innovative solutions for contraception and period care. With a robust pipeline of future blockbuster switches, partnerships with leading retailers such as Boots, Superdrug, Tesco, and Asda, and plans for international expansion, Maxwellia is positioned to lead the evolution of the £288bn global OTC market. Backed by investors including Praetura Ventures, Channel 4 Ventures and the British Business Bank, Maxwellia is redefining consumer healthcare, one innovation at a time.